Search

Illumina Inc

Suletud

SektorTervishoid

186.56 -1.61

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

183.59

Max

190.26

Põhinäitajad

By Trading Economics

Sissetulek

-200M

134M

Müük

-68M

1.1B

P/E

Sektori keskmine

34.582

60.149

Aktsiakasum

1.15

Kasumimarginaal

12.282

Töötajad

8,600

EBITDA

-219M

226M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

-9.56% downside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

30. juuli 2026

Turustatistika

By TradingEconomics

Turukapital

9.3B

29B

Eelmine avamishind

188.17

Eelmine sulgemishind

186.56

Uudiste sentiment

By Acuity

7%

93%

6 / 340 Pingereas Healthcare

Illumina Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

17. juuli 2026, 19:06 UTC

Illumina Inc shares are lower today amid broader market declines, particularly in technology and semiconductor stocks, following significant selling pressure in Asia.

16. juuli 2026, 22:06 UTC

Illumina Inc shares are lower in after-market hours, tracking broader market declines amid geopolitical tensions and mixed economic indicators.

15. juuli 2026, 18:51 UTC

Illumina Inc shares declined Wednesday, pulling back from earlier gains. No specific news was identified to explain this movement amid broader positive market trends.

14. juuli 2026, 19:36 UTC

News

Illumina shares rise as Canaccord raises price target to $190.00, despite a patent ruling against the company in Germany.

10. juuli 2026, 20:06 UTC

Correlated Moves

Illumina Inc shares are lower amid a broader decline in the biotechnology sector. Market volatility is heightened due to geopolitical tensions involving the U.S. and Iran.

9. juuli 2026, 19:11 UTC

News
Correlated Moves

Illumina Inc. appointed Mike Sullivan as Chief Commercial Officer and Julie Coletti as Chief Legal Officer, contributing to a rise in shares amid sector gains.

8. juuli 2026, 20:04 UTC

Correlated Moves

Illumina Inc shares are lower today, influenced by declines in the Life Sciences Tools & Services sector and a drop in the Russell 2000 Index.

7. juuli 2026, 21:41 UTC

Illumina Inc. shares are higher in after-market trading, reflecting ongoing strength despite earlier session pullbacks and broader caution in the technology sector.

6. juuli 2026, 19:52 UTC

Social Media
News

Evercore ISI raised its price target on Illumina to $200, maintaining an Outperform rating. Shares are trading higher amid positive sentiment and social media discussions.

2. juuli 2026, 23:06 UTC

Correlated Moves

Illumina Inc shares declined in after-market trading, reflecting broader trends despite positive movements in European equity indices, including a rise in the DAX.

1. juuli 2026, 20:03 UTC

News

Piper Sandler raised Illumina's price target to $200, contributing to shares trading higher today. The company also expanded its board with a new appointment.

30. juuni 2026, 20:01 UTC

News
Social Media

Illumina Inc shares are lower as Roche launches a competing gene sequencer at a lower price, challenging Illumina's market share in genetic testing technology.

29. juuni 2026, 23:16 UTC

Illumina Inc shares are lower in after-market trading, with no specific news identified to explain the movement. Broader U.S. equities show mixed performance.

26. juuni 2026, 23:16 UTC

Illumina Inc shares are trading lower in after-market hours. Broader market concerns over rising interest rates and inflation may be influencing investor behavior.

25. juuni 2026, 23:26 UTC

Illumina Inc shares are higher in after-market trading, reflecting strong performance above their 20-day moving average despite no specific news driving the move.

24. juuni 2026, 20:02 UTC

News
Social Media

Illumina Inc. shares are higher amid gains in the Life Sciences Tools & Services sector. Barclays raised its price target to $145 from $122.

23. juuni 2026, 22:46 UTC

Illumina Inc shares are higher in after-market trading, reflecting a notable advance since Tuesday's close and strong performance near the upper end of its one-month range.

22. juuni 2026, 19:32 UTC

Illumina Inc's shares are higher today, despite declines in the Nasdaq. The stock remains flat since Thursday, with no specific news driving the movement.

19. juuni 2026, 00:02 UTC

Correlated Moves

Illumina Inc shares are lower in after-market hours, reflecting broader market sentiment as the Russell 2000 Index also declined slightly.

18. juuni 2026, 23:01 UTC

Illumina Inc shares are lower in after-market hours following earlier gains. The stock showed unusual volatility during this session without identifiable news.

17. juuni 2026, 20:03 UTC

Correlated Moves
Macro Event

Illumina Inc shares are lower today, driven by broader market declines and macroeconomic concerns related to the Federal Reserve's monetary policy decisions.

16. juuni 2026, 19:56 UTC

Correlated Moves

Illumina Inc. shares are lower today, following a broader market decline. The stock remains above its 20-day moving average despite recent fluctuations.

15. juuni 2026, 13:02 UTC

Correlated Moves

Illumina Inc shares are higher in pre-market trading, reflecting strong momentum since Friday's close and aligning with the broader Russell 2000 Index trend.

12. juuni 2026, 19:56 UTC

Illumina Inc's shares are lower today, continuing a downward trend since Thursday. The stock remains above its 20-day moving average despite the decline.

11. juuni 2026, 20:03 UTC

Correlated Moves
News

Illumina Inc launched its StrataMap Spatial Solution, enhancing gene detection capabilities. Shares are advancing in Thursday's session, recovering from earlier lows.

10. juuni 2026, 23:11 UTC

Illumina Inc shares are higher in after-market trading, supported by a notable upward trend in the Life Sciences Tools & Services sub-sector.

9. juuni 2026, 19:26 UTC

News

Illumina shares are advancing, supported by a consensus "Hold" rating from analysts and an average price target of $138.38.

8. juuni 2026, 20:06 UTC

News

Illumina Inc launched the StrataMap Spatial Solution, yet shares are declining amid broader market sentiment and sector challenges.

5. juuni 2026, 23:16 UTC

Correlated Moves

Illumina Inc shares are roughly flat in after-market trading, reflecting broader market dynamics amid a slight decline in the Russell 2000 Index.

4. juuni 2026, 19:51 UTC

Illumina Inc shares are lower today, breaking a trend of higher closes since Wednesday. No specific news was identified to explain this decline.

Võrdlus sarnastega

Hinnamuutus

Illumina Inc Prognoos

Hinnasiht

By TipRanks

-9.56% langus

12 kuu keskmine prognoos

Keskmine 168.8 USD  -9.56%

Kõrge 210 USD

Madal 95 USD

Põhineb 15 Wall Streeti analüütiku instrumendi Illumina Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

15 ratings

8

Osta

4

Hoia

3

Müü

Sentiment

By Acuity

6 / 340 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
help-icon Live chat